Related Experiment Video
Updated: Feb 7, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Special issues in the treatment of paediatric bipolar disorder
1The Department of Psychiatry and Behavioural Sciences, Stanford University School of Medicine, USA.
Insights
Paediatric bipolar disorder (PBD) treatment research is advancing, with growing evidence supporting mood stabilizers like lithium, divalproex, and carbamazepine for children and adolescents. Novel agents and a proposed treatment algorithm offer new hope for managing this complex condition.
Area of Science:
- Child and Adolescent Psychiatry
- Neuroscience
- Pharmacology
Background:
- Paediatric bipolar disorder (PBD) affects 1% of youth, with treatment research lagging behind adult bipolar disorder (BD).
- PBD presents unique challenges, including rapid cycling, mixed states, and high comorbidity with behavioral and attention disorders.
- Diagnosing PBD in children requires careful consideration of developmental factors and semi-structured interviews.
Purpose of the Study:
- To discuss special considerations in treating PBD.
- To review current literature on PBD pharmacotherapy.
- To propose a treatment algorithm for PBD.
Main Methods:
- Review of current literature on PBD pharmacotherapy.
- Discussion of diagnostic and treatment challenges specific to PBD.
- Development of a proposed treatment algorithm based on available data.
Main Results:
- Mood stabilizers such as lithium, divalproex, and carbamazepine show growing evidence of efficacy in PBD, primarily from open, uncontrolled studies.
- Atypical antipsychotics and newer anticonvulsants represent more recent treatment options.
- Novel agents investigated for adult BD may also be applicable to PBD.
Conclusions:
- Lithium, divalproex, and carbamazepine are considered effective mood stabilizers for PBD.
- Atypical antipsychotics and newer anticonvulsants are emerging treatment options.
- A proposed treatment algorithm can guide PBD management.
Abstract:
Paediatric bipolar disorder (PBD) is an increasingly diagnosed disorder affecting an estimated 1% of children and adolescents. Pharmacological treatment studies in PBD have lagged far behind those in adults. Children are currently treated with pharmacological agents, most of which have proven efficacy in adults. However, PBD is distinct from adult forms of bipolar disorder (BD) and may present unique treatment challenges. PBD often presents with rapid cycling and mixed manic states and a high co-morbidity with behavioural and attention disorders. Early onset depression may also be an early sign of PBD. Due to developmental considerations, the diagnosis of BD may be difficult to make in children without semi-structured interviews. This report discusses the special issues that should be considered when treating PBD and reviews the current literature regarding pharmacotherapy of this population. Mood stabilisers have been studied mostly in an open, uncontrolled fashion but there is growing evidence that lithium, divalproex and carbamazepine are effective in treating PBD. More recent treatment options include atypical antipsychotics and newer anticonvulsants. Other novel agents are currently being investigated in adult BD and may prove applicable to the paediatric form. Finally, based on the available data, a treatment algorithm for PBD is proposed.
Related Concept Videos
Special Staining Techniques
Bipolar Disorder
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Ethical Issues
Ethical Concerns in Healthcare:
Bipolar Junction Transistor
Introduction to Special Senses

